Sianny Christanti

Sianny has extensive experience in process development, late-stage process qualification, and the manufacturing of pharmaceuticals, gained during a well-respected 22-year career at Merck. During her time at Merck, she supported the process validation and BLA filing of Gardasil 4® vaccine and led the process development of a multitude of preclinical assets in both vaccine and therapeutic programs, including live viruses, VLPs, and recombinant protein modalities. In her most recent role at Merck, Sianny led a group providing process and analytical laboratory support for all Merck commercial vaccines. In addition to her strong technical expertise in process development, Sianny possesses excellent leadership abilities as demonstrated by her success in leading and managing cross-functional projects.

Sianny has a BS in chemical engineering from the University of Wisconsin — Madison.